๐Ÿ”Ž Trials Near Me

Home โ€บ Lymphoma

Lymphoma clinical trials recruiting in the U.S.

141 studies for Lymphoma are recruiting participants at sites across the United States.

Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.

Cities with the most studies

By state

Recently updated studies

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07013435

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07014293

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

RecruitingObservational study
Ages 3 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT01441089

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

RecruitingObservational study
Ages 18 to 120 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00006518

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT03418038

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

RecruitingPhase 1/2
Ages 18 to 120 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT03223610

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

RecruitingPhase 1
24 Months โ€“ 18 Years ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06441331

Epco, Zanu, Ritux for R/R FL or MZL

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06563596

Rutgers University Study of the Genetics of Blood Cancers

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 110 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07714044

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

RecruitingPhase 1/2
Up to age 25 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT04094610

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

RecruitingPhase 2
Ages 18 to 99 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT04083495

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT02974647

Precise Oncology Interventions in Nutrition and Training (OnPoint)

RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT06534918

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Sep 22, 2026 ยท NCT03258567

Collection of Tissue Samples for Cancer Research

RecruitingObservational study
2 Months ยท All sexes ยท Updated Sep 16, 2026 ยท NCT00900198

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

RecruitingPhase 1
Ages 18 to 100 ยท All sexes ยท Updated Sep 15, 2026 ยท NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

RecruitingPhase 1/2
Ages 12 and older ยท All sexes ยท Updated Sep 14, 2026 ยท NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RecruitingPhase 1/2
12 Months โ€“ 21 Years ยท All sexes ยท Updated Sep 11, 2026 ยท NCT04870944

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.